Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Tuesday, 12 December 2017

HeartStitch® Leading the growth of PFO Closure in Italy

 
HeartStitch® Leading the growth of PFO Closure in Italy
HEARTSTITCH® ITALIAN DISTRIBUTOR, KARDIA LAUNCHES EXPANSION OF NOBLESTITCH™ THROUGHOUT ITALY AFTER PUBLICATION OF STRONG ITALIAN CLINICAL RESULTS MILAN, Dec. 11, 2017 /PRNewswire/ -- Kardia announced expansion plan of the NobleStitch™ EL at a recent meeting organized by Professor...
Read more

Lilly Announces 8 Percent Dividend Increase
INDIANAPOLIS, December 11,2017 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced an 8 percent increase in its quarterly dividend. The dividend for the first quarter of 2018 will be $0.5625 per share on outstanding common stock. This raises the...
Read more

RAPT Touch and OEM Partner to Demonstrate RAPT's Latest Technology Designed for Windows Ink and the Education Market, at BETT 2018
RAPT ENABLED INTERACTIVE FLAT PANELS TO BE DEMONSTRATED IN THE MICROSOFT BOOTH DUBLIN, Dec. 11, 2017 /PRNewswire/ -- RAPT Touch, the leader in alternative touchscreen technologies, will demonstrate its latest advancements in Interactive Flat Panel technology designed for the education...
Read more

Daiichi Sankyo Presents Phase 1 Data for EZH1/2 Dual Inhibitor DS-3201 in Patients with Non-Hodgkin Lymphomas at the 59th Annual Meeting of the American Society of Hematology
-  Preliminary exploratory efficacy results from phase 1 study show an overall response rate of 58.8 percent with single agent DS-3201, an investigational and potential first-in-class EZH1/2 dual inhibitor, in patients with relapsed or refractory non-Hodgkin lymphomas -  In subgroup an...
Read more

tripgift.com Launches First eGift Card for Worldwide Hotels, Experiences, Cruises, Tours & Car Rental
LONDON, December 12, 2017 /PRNewswire/ -- Today tripgift.com has launched the first worldwide eGift card for Travel, Lifestyle Experiences and Digital Media with a unique choice of 330,000 Hotels, Villas & Apartments, 50,000 Things to do, 16 Cruise Lines, 2,000 Tours, 500 Car...
Read more

AI for Earth can be a game-changer for our planet, says Microsoft President Brad Smith
PARIS, Dec. 11, 2017 /PRNewswire/ -- On Monday, Microsoft Corp. President Brad Smith announced a $50 million commitment, over the next five years, to put artificial intelligence in the hands of individuals and organizations around the world who are working to protect our planet through a...
Read more

$55.9 Billion Semiconductor Equipment Forecast - New Record with Korea at Top
TOKYO, Dec. 11, 2017 /PRNewswire/ -- Today, SEMI, the global industry association representing the electronics manufacturing supply chain, released its Year-end Forecast at the annual SEMICON Japan exposition. SEMI projects that worldwide sales of new semiconductor manufacturing equipment...
Read more